trafermin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2016
012319972016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSE Oral mucositis is a frequent and dose-limiting side effect of radiotherapy or chemotherapy in cancer patients. We… (More)
Is this relevant?
2016
2016
We investigated the efficacy, safety, and clinical significance of trafermin, a recombinant human fibroblast growth factor (rhFGF… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
The purpose of this study was to confirm the therapeutic effects of mixed sheets consisting of peripheral blood mononuclear cells… (More)
Is this relevant?
2012
2012
Stroke remains one of the main causes of death and disability worldwide. The aging of the population is likely to result in a… (More)
Is this relevant?
Review
2011
Review
2011
INTRODUCTION Basic fibroblast growth factor (bFGF) has been shown to reduce volume in acute ischemic stroke models, and to… (More)
Is this relevant?
2010
2010
OBJECTIVE To present the clinical results of closing chronic tympanic membrane (TM) perforations using basic fibroblast growth… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Entero-related fistulae are often intractable. Recently, growth factors were generally in sight with the development of… (More)
Is this relevant?
2005
2005
We used trafermin (recombinant human basic fibroblast growth factor) to treat a skin ulcer (diameter, 1 cm; depth, 2 mm) that… (More)
Is this relevant?
2002
2002
BACKGROUND Trafermin (basic fibroblast growth factor) has been shown to reduce infarct volume in acute ischemic stroke models… (More)
Is this relevant?
1997
1997
The fate of trafermin (recombinant human basic fibroblast growth factor) was examined after intravenous administration of its… (More)
Is this relevant?